AI, Oppenheimer
Shares of Nektar Therapeutics (NASDAQ:NKTR) added ~9% in the premarket on Friday after Oppenheimer upgraded the biopharma to ...
Goldman Sachs analysts are cautioning that “confidence in the US growth story is moderating” and the U.S. stock market may continue to lag behind other global markets.
Netflix’s CCO Bela Bajaria believes Oppenheimer would have thrived on streaming. But would it really match its box office ...
Shares of Roblox (NYSE:RBLX) are higher on Wednesday as the online gaming platform gears up for its highly anticipated "The ...
Oppenheimer reiterates a Perform rating on Cartesian Therapeutics (RNAC) without a price target following the company’s Q4 report. The ...
Oppenheimer will be released on Netflix on March 21, 2025. The movie will be made available to stream on OTT platform with a ...
Oppenheimer Holdings' profit margin is lacking behind key peers, particularly Morgan Stanley, who is also a key competitor.
Oppenheimer lowered the firm’s price target on WhiteHorse Finance (WHF) to $11 from $12 on NAV decline, while keeping a Perform rating on the ...
“Oppenheimer” finally premiered Friday in the nation where two cities were obliterated 79 years ago by the nuclear weapons invented by the American scientist who was the subject of the Oscar ...
Showtime has cast David Dastmalchian ( Oppenheimer) in Dexter: Resurrection in the guest starring role of “Gareth.” ...
Oppenheimer analyst Jay Olson downgraded Sutro Biopharma (STRO) to Perform from Outperform after the company reported Q4 results and announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results